ISLAA Highlights 2014

Topics and Speakers

Embryology, Anatomy & Histopathology of the Left Atrial Appendage

                Samuel Asirvatham

Impact of LAA Exclusion on Cardiovascular Physiology and Systemic Homeostasis

                Dhanunjaya Lakkireddy

Understanding the Role of LAA in Systemic Thromboembolization

                Madhu Reddy

The Role of LAA in Atrial Arrhythmias Origin and Maintenance

                Andrea Natale

Risk Assessment Tools for Stroke Prophylaxis and Bleeding – Practical Use

                Loren Berenbom

Managing Antiplatelet Therapy and Anticoagulants in Patients with CAD and Atrial Fibrillation

                Peter Tadros

Everyone with CHADS2 Score of 2 or More Should Be Considered for LAA Closure/Ligation

                Saibal Kar

                Moussa Mansour

Essentials of Transseptal Puncture as is Relevant to LAA Closure or Ligation

                Réda Ibrahim

Dry Pericardial Access: Rules of Engagement

                Randall Lee

Patient Selection: Who is a Good Candidate for LAA Exclusion

                Rodney Horton

Understanding Thoracic Anatomy for Minimally Invasive LAA Surgical Ligation: A Surgeon’s Percpective

                Steven Hoff

Evolution of Percutaneous Techniques in LAA Occlusion or Exclusion

                David R. Holmes Jr.

Past, Present, and Future of Surgical Left Atrial Appendage Exclusion

                James Edgerton

Is LAA Occlusion/Exclusion Good Enough to Allow for Discontinuation of Coumadin in Patients with AF and Higher Risk for Thromboembolization?

                Douglas Gibson

                Zoltan Turi

How to Set Up a LAA Exclusion Program

                Vijay Swarup

Transesophageal Echo in LAA Exclusion

                Swaminatha  Gurudevan

The Role of CT Imaging in Left Atrial Appendage Exclusion

                Douglas Gibson

Tips and Tricks to Prevent Complications During LAA Exclusion

                Rodney Horton

Managing Complications in LAA Exclusion Procedures

                David R. Holmes Jr.

Post Procedural LAA Exclusion Leak – Mechanisms, Implications and Treatment

                Andrea Natale

Post Procedural Anticoagulation Management after LAA Exclusion – Understanding an Imperfect Science

                Matthew Earnest

Should LAA be Ligated Routinely during an Open Heart Surgery?

                Richard Whitlock

                James Edgerton

Impact of Surgical Ablation or Exclusion of LAA – Implications to Rhythm Control

                Marc Gillinov

LAA Ligation as an Adjunctive Therapy for AF Ablation – The LAALA AF Study

                Dhanunjaya Lakkireddy

Who Should Perform LAA Occlusion/Exclusion Procedures? Surgron/EP/Interventional

                Dhanunjaya Lakkireddy

                Saibal Kar

Watchman Trials

                David R. Holmes Jr.

Lariat Trials

                Abdi Rasekh

Amplatzer Cardiac Plug Trials

                Réda Ibrahim

AtriClip & Other Surgical Tool Trials

                James Edgerton

Early Experience with Wavecrest Technology

                Andrea Natale

Why Should the LAA Exclusion be a Program and not a Procedure?

                Matthew Earnest

Cost Effectiveness of LAA Exclusion

                Miguel Valderbanno

LAA Ligation and Occlusion Technology in the Incubator

                Samuel Asirvatham

Evolution of Anticoagulation for Stroke Prophylaxis in Patients with Atrial Fibrillation

                Daniel Singer

Novel Anticoagulant Trial Review: RELY, Rocket, Aristotle & Engage AF

                Michael Ezekowitz

New Generation Anti-coagulation Agents are a Better Choice than Warfarin in the Management of AF

                Sanjeev Saksena

                John Camm

Peri-Procedural Management of Oral Anticoagulants

                Luigi DiBiase

Understanding the Antidotes for Oral and Systemic Anticoagulants

                Gerald Nacarelli

Stroke Prophylaxis on a Global Scale – Why Oral Anticoagulants are Still the Best Answer

                John Camm

Systemic Anticoagulation – How do you Select Which Drug for Whom?

                Jonathon Piccini

Optimization of Stroke Prophylaxis Strategies in Non-Valvular AF – Drugs, Devices or Both?

                Samuel Asirvatham

Management of Non-Valvular AF and Stroke – Hurdles I Access to Appropriate Care

                Michael Ezekowitz

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Photo Gallery

 

Videos

Click here to view videos.

 

 

Copyright © ISLAA-KC. All Rights Reserved. Privacy Policy
Site Created by KC Web Specialists, LLC.